VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 97 filers reported holding VERONA PHARMA PLC in Q1 2023. The put-call ratio across all filers is 1.24 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $221,961 | -31.7% | 15,350 | -24.0% | 0.03% | -24.4% |
| Q1 2024 | $325,018 | +9.9% | 20,200 | +35.8% | 0.04% | -29.3% |
| Q4 2023 | $295,775 | -67.4% | 14,878 | -73.3% | 0.06% | -77.9% |
| Q3 2023 | $907,649 | +105.7% | 55,684 | +166.8% | 0.26% | +93.4% |
| Q2 2023 | $441,255 | +2449.3% | 20,873 | +2321.5% | 0.14% | +2166.7% |
| Q1 2023 | $17,309 | +7.4% | 862 | +39.7% | 0.01% | 0.0% |
| Q4 2022 | $16,122 | – | 617 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 901,943 | $3,716,000 | 2.47% |
| venBio Partners LLC | 456,770 | $1,882,000 | 1.60% |
| Aisling Capital Management LP | 443,596 | $1,828,000 | 0.80% |
| Vivo Capital, LLC | 1,492,951 | $6,151,000 | 0.56% |
| NEA Management Company, LLC | 1,219,674 | $5,025,000 | 0.26% |
| Novo Holdings A/S | 740,740 | $3,052,000 | 0.20% |
| Orbimed Advisors | 1,250,396 | $5,152,000 | 0.09% |
| Clear Creek Financial Management, LLC | 37,500 | $170,000 | 0.06% |
| Tekla Capital Management LLC | 253,179 | $1,043,000 | 0.05% |
| WEDBUSH SECURITIES INC | 70,950 | $292,000 | 0.04% |